These therapies, Semaglutide and Wegovy, represent a significant shift in approaches to treating type 2 diabetes and, increasingly, obesity . They work as GLP-1 GLP-1 analogs , mimicking the action of a https://weight-reduction-in-diab568425.activoblog.com/profile